Biocon submits press release

22 Aug 2019 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Biocon has informed about submission of the press release titled ‘Biocon’s Malaysia Insulin Glargine Manufacturing Facility Receives EU GMP Certification, Provides Fillip to its Capacity’. The above information will also be available on the website of the Company at www.biocon.com.  

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

289.40 -0.15 (-0.05%)
25-Apr-2024 10:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1500.55
Dr. Reddys Lab 5979.70
Cipla 1386.55
Zydus Lifesciences 930.20
Lupin 1585.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.